Video tool provides significant improvement in health literacy among patients with prostate cancer
the ONA take:
Patients often do not understand the meanings of key terms used by clinicians in reference to prostate care, but a novel video-based tool was found to significantly improve patients’ understanding of these terms, according to a study initiated by the Winship Cancer Institute of Emory University.
A previous study by this team of investigators revealed a severe lack of comprehension of key terms such as incontinence, urinary function, and bowel habits among patients with prostate cancer treated at a hospital in Atlanta, Georgia.
Using those results as an incentive, the researchers developed an application with narrated animations depicting 26 terms routinely used in talking with patients about prostate cancer.
Participants’ comprehension was tested before and after viewing the application. The study findings demonstrated statistically significant improvements in comprehension of most terms; for example, 14% of the men understood incontinence before viewing the application; however, after viewing it, 50% of them demonstrated comprehension of the term.
This study illustrates a need for better access to health care information among men with prostate cancer to help them make more informed decisions about their care. In addition, the investigators demonstrated the effectiveness of using video tools for patient education.
Novel video-based tool was found to significantly improve patients’ understanding of cancer terms.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Patients Undergoing Multiple Systemic Therapies for Metastatic Prostate Cancer Expect a Cure
- FDA Grants Priority Review to Ceritinib for First-line Treatment of ALK+ NSCLC
- Overall Health Worse in African American Men Undergoing Active Surveillance For Prostate Cancer
- Clinical Benefit of Simtuzumab Inconsistent for Myelofibrosis
- Follow-up Rates in Active Surveillance for Prostate Cancer Higher in University-Based vs Safety-Net Hospitals
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|